New Cancer Discoveries in Molecular Oncology
Molecular Oncology Program
This program aims to find and develop new ways to prevent and treat cancers, and to identify markers that help understand and manage the disease.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11099773 on NIH RePORTER |
What this research studies
This program at the HDFCCC focuses on finding new ways to prevent and treat cancer, and on discovering biomarkers that can help guide care. Researchers work across different areas, from basic lab science and computer analysis to real-world patient applications. The goal is to bridge the gap between scientific discoveries and patient care, ensuring that new findings can quickly benefit those with cancer. This includes understanding how genetics affect cancer, finding ways to target cancer's signaling pathways, and creating new tools to study how tumors interact with the body.
Who could benefit from this research
Good fit: Patients with various types of cancer, or those at risk, could potentially benefit from the future therapies and diagnostics developed through this program.
Not a fit: Patients whose conditions are not related to cancer or the specific molecular pathways being studied may not directly benefit from this particular research program.
Why it matters
Potential benefit: If successful, this program could lead to new and more effective treatments, better ways to prevent cancer, and improved methods for diagnosing and monitoring the disease.
How similar studies have performed: Comprehensive cancer center programs like this have a strong track record of fostering collaborative research that leads to significant advancements in cancer care.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Craik, Charles Scott — University of California, San Francisco
- Study coordinator: Craik, Charles Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.